Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T22:38:42.420Z.
Calculation as of: 2026-10-06T22:38:42.420Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c51f7bb38e0467dbdaec2b87e904118633479c78190bb705d814f7e841715b6d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
SELLAS Life Sciences Group, Inc.
Market Cap
$2.11B
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.11B
EV/EBIT Ratio
14.31x
TTM Avg
15.46x
3Y Avg
18.22x
5Y Avg
20.56x
Market Cap
$2.13B
EV/EBIT Ratio
N/A
TTM Avg
501.30x
3Y Avg
501.30x
5Y Avg
501.30x
Market Cap
$2.06B
EV/EBIT Ratio
N/A
TTM Avg
4584.86x
3Y Avg
4584.86x
5Y Avg
4584.86x
Market Cap
$2.17B
EV/EBIT Ratio
23.68x
TTM Avg
17.43x
3Y Avg
12.93x
5Y Avg
8.03x
Market Cap
$2.05B
EV/EBIT Ratio
110.67x
TTM Avg
307.23x
3Y Avg
485.43x
5Y Avg
1367.82x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | $2.11B | N/A | N/A | N/A | N/A |
| Vera Therapeutics, Inc. (VERA)vs › | $2.11B | N/A | N/A | N/A | N/A |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | 14.31x | 15.46x | 18.22x | 20.56x |
| GeneDx Holdings Corp. (WGS)vs › | $2.13B | N/A | 501.30x | 501.30x | 501.30x |
| Alvotech (ALVO)vs › | $2.08B | 71.54x | 53.16x | 49.42x | 49.42x |
| Viridian Therapeutics, Inc. (VRDN)vs › | $2.06B | N/A | N/A | N/A | N/A |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.06B | N/A | 4584.86x | 4584.86x | 4584.86x |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.17B | 23.68x | 17.43x | 12.93x | 8.03x |
| Vericel Corporation (VCEL)vs › | $2.05B | 110.67x | 307.23x | 485.43x | 1367.82x |
| Pharvaris N.V. (PHVS)vs › | $2.17B | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
